先端医科学研究所

Medicine & Life Sciences

1. Neoplasms 100%
2. Melanoma 78%
3. Neoplastic Stem Cells 70%
4. T-Lymphocytes 64%
5. Glioma 62%
6. Melanoma-Specific Antigens 59%
7. Immunotherapy 54%
8. Tumor-Infiltrating Lymphocytes 48%
9. Optogenetics 42%
10. Neoplasm Antigens 41%
11. Stem Cells 40%
12. Brain 30%
13. Antigens 30%
14. Glioblastoma 28%
15. Neurons 27%
16. Genes 27%
17. Epitopes 25%
18. Neoplasm Metastasis 25%
19. Cell Line 24%
20. Therapeutics 24%
21. HLA-A2 Antigen 24%
22. Sulfasalazine 24%
23. Epithelial-Mesenchymal Transition 23%
24. Peptides 23%
25. Dendritic Cells 23%
26. Astrocytes 23%
27. Graft vs Host Disease 23%
28. Proteins 19%
29. Growth 19%
30. Phenotype 19%
31. Antibodies 18%
32. Carcinogenesis 18%
33. Stomach Neoplasms 17%
34. Tumor Microenvironment 17%
35. Osteosarcoma 16%
36. Melanocytes 16%
37. Idiopathic Thrombocytopenic Purpura 16%
38. Neural Stem Cells 16%
39. In Vitro Techniques 16%
40. Cholangiocarcinoma 15%
41. Down-Regulation 15%
42. Breast Neoplasms 15%
43. Neuroglia 15%
44. Interleukin-2 15%
45. HLA-A24 Antigen 15%
46. Brain Neoplasms 14%
47. Cytotoxic T-Lymphocytes 14%
48. Gene Expression 13%
49. Vaccination 13%
50. Apoptosis 13%
51. Oligodendroglia 13%
52. Induced Pluripotent Stem Cells 13%
53. Reactive Oxygen Species 13%
54. Lacrimal Apparatus 13%
55. Transgenic Mice 13%
56. Dorsal Raphe Nucleus 12%
57. Stomach 12%
58. Mutation 12%
59. Forensic Anthropology 12%
60. Immunosuppressive Agents 12%
61. Colonic Neoplasms 12%
62. Oxidation-Reduction 12%
63. Fibroblasts 12%
64. Epithelial Cells 11%
65. Epithelial Cell Adhesion Molecule 11%
66. Cadherins 11%
67. Serotonin 11%
68. Adenocarcinoma of Lung 11%
69. T-Lymphocyte Epitopes 11%
70. Survival 11%
71. gp100 Melanoma Antigen 11%
72. Colorectal Neoplasms 11%
73. Corpus Striatum 11%
74. Serum 11%
75. Messenger RNA 11%
76. Cisplatin 11%
77. Oxidative Stress 11%
78. Complementary DNA 11%
79. SARS Virus 10%
80. Catenins 10%
81. Cell Proliferation 10%
82. Cell Cycle 10%
83. Protein Isoforms 10%
84. HLA Antigens 10%
85. Tumor Necrosis Factor-alpha 10%
86. Biomarkers 10%
87. Adenocarcinoma 10%
88. Cytokines 10%
89. Oryzias 9%
90. Macrophages 9%
91. Amino Acid Transport System X-AG 9%
92. Population 9%
93. Ligands 9%
94. Cancer Vaccines 9%
95. Glutathione 9%
96. Organoids 9%
97. Squamous Cell Carcinoma of Head and Neck 9%
98. Cell Survival 9%
99. Non-Small Cell Lung Carcinoma 9%
100. MART-1 Antigen 9%